UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 29, 2014

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 000-10030

APPLE INC.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

(408) 996-1010

(Registrant s telephone number, including area code)

Indicate by

check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to

file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule

405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer,

an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

861,381,000 shares of common stock, par value $0.00001, issued and outstanding as

of April 11, 2014

Table of Contents

Apple Inc.

Form 10-Q

For the Fiscal Quarter Ended March 29, 2014

TABLE OF CONTENTS

Page

Part I

Item 1.

Financial Statements

Item 2.

Management s Discussion and Analysis of Financial Condition and Results of

Operations

23

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

37

Item 4.

Controls and Procedures

37

Part II

Item 1.

Legal Proceedings

38

Item 1A.

Risk Factors

39

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

49

Item 3.

Defaults Upon Senior Securities

49

Item 5.

Other Information

49

Item 6.

Exhibits

50

Table of Contents

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(In millions, except number of shares which are reflected in thousands and per share amounts)

Three Months Ended

Six Months Ended

March 29,

2014

March 30,

2013

March 29,

2014

March 30,

2013

Net sales

45,646

43,603

103,240

98,115

Cost of sales

27,699

27,254

63,447

60,706

Gross margin

17,947

16,349

39,793

37,409

Operating expenses:

Research and development

1,422

1,119

2,752

2,129

Selling, general and administrative

2,932

2,672

5,985

5,512

Total operating expenses

4,354

3,791

8,737

7,641

Operating income

13,593

12,558

31,056

29,768

Other income/(expense), net

225

347

471

809

Income before provision for income taxes

13,818

12,905

31,527

30,577

Provision for income taxes

3,595

3,358

8,232

7,952

Net income

10,223

9,547

23,295

22,625

Earnings per share:

Basic

11.69

10.16

26.31

24.09

Diluted

11.62

10.09

26.16

23.90

Shares used in computing earnings per share:

Basic

874,757

939,629

885,415

939,273

Diluted

879,528

946,035

890,490

946,626

Cash dividends declared per common share

3.05

2.65

6.10

5.30

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)

(In millions)

Three Months Ended

Six Months Ended

March 29,

2014

March 30,

2013

March 29,

2014

March 30,

2013

Net income

10,223

9,547

23,295

22,625

Other comprehensive income/(loss):

Change in foreign currency translation, net of tax

(19

(51

(86

(77

Change in unrecognized gains/losses on derivative instruments:

Change in fair value of derivatives, net of tax

(109

457

104

603

Adjustment for net (gains)/losses realized and included in net income, net of tax

(13

42

59

154

Total change in unrecognized gains/losses on derivative instruments, net of tax

(122

499

163

757

Change in unrealized gains/losses on marketable securities:

Change in fair value of marketable securities, net of tax

235

(52

193

(118

Adjustment for net (gains)/losses realized and included in net income, net of tax

(39

(44

(50

(97

Total change in unrealized gains/losses on marketable securities, net of tax

196

(96

143

(215

Total other comprehensive income/(loss)

55

352

220

465

Total comprehensive income

10,278

9,899

23,515

23,090

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(In millions, except number of shares which are reflected in thousands)

March 29,

2014

September 28,

2013

ASSETS:

Current assets:

Cash and cash equivalents

18,949

14,259

Short-term marketable securities

22,401

26,287

Accounts receivable, less allowances of $88 and $99, respectively

9,700

13,102

Inventories

1,829

1,764

Deferred tax assets

4,014

3,453

Vendor non-trade receivables

6,120

7,539

Other current assets

7,528

6,882

Total current assets

70,541

73,286

Long-term marketable securities

109,239

106,215

Property, plant and equipment, net

15,120

16,597

Goodwill

2,055

1,577

Acquired intangible assets, net

3,928

4,179

Other assets

5,106

5,146

Total assets

205,989

207,000

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

18,914

22,367

Accrued expenses

15,984

13,856

Deferred revenue

8,310

7,435

Total current liabilities

43,208

43,658

Deferred revenue non-current

3,164

2,625

Long-term debt

16,962

16,960

Other non-current liabilities

22,476

20,208

Total liabilities

85,810

83,451

Commitments and contingencies

Shareholders equity:

Common stock and additional paid-in capital, $0.00001 par value: 1,800,000 shares authorized; 861,745 and 899,213 shares issued

and outstanding, respectively

21,496

19,764

Retained earnings

98,934

104,256

Accumulated other comprehensive income/(loss)

(251

(471

Total shareholders equity

120,179

123,549

Total liabilities and shareholders equity

205,989

207,000

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(In millions)

Six Months Ended

March 29,

2014

March 30,

2013

Cash and cash equivalents, beginning of the period

14,259

10,746

Operating activities:

Net income

23,295

22,625

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation and amortization

4,031

3,280

Share-based compensation expense

1,377

1,120

Deferred income tax expense

2,059

1,957

Changes in operating assets and liabilities:

Accounts receivable, net

3,401

3,846

Inventories

(65

(454

Vendor non-trade receivables

1,419

1,510

Other current and non-current assets

14

1,269

Accounts payable

(2,375

(4,422

Deferred revenue

1,414

1,541

Other current and non-current liabilities

1,638

3,658

Cash generated by operating activities

36,208

35,930

Investing activities:

Purchases of marketable securities

(90,360

(81,163

Proceeds from maturities of marketable securities

10,869

9,243

Proceeds from sales of marketable securities

80,241

49,188

Payments made in connection with business acquisitions, net

(559

(299

Payments for acquisition of property, plant and equipment

(3,367

(4,325

Payments for acquisition of intangible assets

(163

(429

Other

(23

(93

Cash used in investing activities

(3,362

(27,878

Financing activities:

Proceeds from issuance of common stock

341

275

Excess tax benefits from equity awards

363

502

Taxes paid related to net share settlement of equity awards

(430

(588

Dividends and dividend equivalents paid

(5,430

(4,984

Repurchase of common stock

(23,000

(1,950

Cash used in financing activities

(28,156

(6,745

Increase in cash and cash equivalents

4,690

1,307

Cash and cash equivalents, end of the period

18,949

12,053

Supplemental cash flow disclosure:

Cash paid for income taxes, net

5,369

4,258

Cash paid for interest

161

See accompanying Notes to Condensed Consolidated Financial Statements.

Table of Contents

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,

manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and

applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the

Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers; small and mid-sized businesses; and

education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions

have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the

amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates.

These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal

year ended September 28, 2013, included in its Annual Report on Form 10-K (the 2013 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. An additional week is included

in the first fiscal quarter approximately every six years to realign fiscal quarters with calendar quarters. The Company s fiscal years 2014 and 2013 each include 52 weeks. Unless otherwise stated, references to particular years, quarters or

months refer to the Company s fiscal years ended in September and the associated quarters or months of those fiscal years.

During the first quarter of 2014, the Company adopted updated accounting standards that (i) required disclosure of additional

information about the amounts reclassified out of Accumulated Other Comprehensive Income ( AOCI ) by component and (ii) required gross and net disclosures about offsetting assets and liabilities. The adoption of these updated

standards only impacted the disclosures in the Notes to the Condensed Consolidated Financial Statements; accordingly, the adoption had no impact on the Company s financial position or results of operations. The Company has provided these

additional disclosures in this Form 10-Q in Note 8, Comprehensive Income and Note 2, Financial Instruments, respectively.

Revenue Recognition

In 2013, the Company s combined best estimates of

selling price ( ESPs ) for the unspecified software upgrade rights and the rights to receive the non-software services included with its qualifying hardware devices ranged from $5 to $25. Beginning in the first quarter of 2014, the Company

adjusted the combined ESPs for Mac from $20 to $40 to reflect additions to unspecified software upgrade rights related to expansion of bundled essential software.

Table of Contents

Earnings Per Share

Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period. Diluted earnings per share

is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the number of additional shares of common stock that would have been

outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s employee stock purchase plan and unvested restricted stock units

( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury stock method, an increase in the fair market value of the

Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table

shows the computation of basic and diluted earnings per share for the three- and six-month periods ended March 29, 2014 and March 30, 2013 (in thousands, except net income in millions and per share amounts):

Three Months Ended

Six Months Ended

March 29,

2014

March 30,

2013

March 29,

2014

March 30,

2013

Numerator:

Net income

10,223

9,547

23,295

22,625

Denominator:

Weighted-average shares outstanding

874,757

939,629

885,415

939,273

Effect of dilutive securities

4,771

6,406

5,075

7,353

Weighted-average diluted shares

879,528

946,035

890,490

946,626

Basic earnings per share

11.69

10.16

26.31

24.09

Diluted earnings per share

11.62

10.09

26.16

23.90

Potentially dilutive securities, the effect of which would have been antidilutive, were not significant

for the three- and six-month periods ended March 29, 2014 and the three- and six-month periods ended March 30, 2013. The Company excluded these securities from the computation of diluted earnings per share.

Table of Contents

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized

gains, gross unrealized losses and fair value by significant investment category recorded as cash and cash equivalents or short- or long-term marketable securities as of March 29, 2014 and September 28, 2013 (in millions):

March 29, 2014

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

10,948

10,948

10,948

Level 1 (a):

Money market funds

3,203

3,203

3,203

Mutual funds

4,063

(213

3,850

3,850

Subtotal

7,266

(213

7,053

3,203

3,850

Level 2 (b):

U.S. Treasury securities

24,645

12

(26

24,631

1,359

5,445

17,827

U.S. agency securities

10,766

(24

10,747

234

1,340

9,173

Non-U.S. government securities

6,406

42

(109

6,339

10

480

5,849

Certificates of deposit and time deposits

3,344

3,344

1,735

771

838

Commercial paper

2,627

2,627

1,350

1,277

Corporate securities

63,575

351

(145

63,781

110

8,373

55,298

Municipal securities

4,117

32

(3

4,146

839

3,307

Mortgage- and asset-backed securities

17,004

34

(65

16,973

26

16,947

Subtotal

132,484

476

(372

132,588

4,798

18,551

109,239

Total

150,698

476

(585

150,589

18,949

22,401

109,239

September 28, 2013

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

8,705

8,705

8,705

Level 1 (a):

Money market funds

1,793

1,793

1,793

Mutual funds

3,999

(197

3,802

3,802

Subtotal

5,792

(197

5,595

1,793

3,802

Level 2 (b):

U.S. Treasury securities

27,642

24

(47

27,619

431

7,554

19,634

U.S. agency securities

16,878

12

(52

16,838

177

3,412

13,249

Non-U.S. government securities

5,545

35

(137

5,443

50

313

5,080

Certificates of deposit and time deposits

2,344

2,344

1,264

844

236

Commercial paper

2,998

2,998

1,835

1,163

Corporate securities

54,586

275

(252

54,609

8,077

46,532

Municipal securities

6,257

45

(22

6,280

1,114

5,162

Mortgage- and asset-backed securities

16,396

23

(89

16,330

16,322

Subtotal

132,646

414

(599

132,461

3,761

22,485

106,215

Total

147,143

414

(796

146,761

14,259

26,287

106,215

(a)

The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.

(b)

The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and

liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Table of Contents

The Company may sell certain of its marketable securities prior to their stated maturities

for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net realized gains or losses recognized by the Company related to such sales were not significant during the three- and six-month

periods ended March 29, 2014 and March 30, 2013. The maturities of the Company s long-term marketable securities generally range from one to five years.

As of March 29, 2014 and September 28, 2013, gross unrealized losses related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.

As of March 29, 2014, the Company considers the declines in market value of its marketable securities investment

portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company typically invests in highly-rated securities, and its investment policy limits the amount of credit exposure to any one

issuer. The policy generally requires investments to be investment grade, with the primary objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When

evaluating an investment for other-than-temporary impairment the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes

in market interest rates, and the Company s intent to sell, or whether it is more likely than not it will be required to sell the investment before recovery of the investment s cost basis. During the three- and six-month periods ended

March 29, 2014 and March 30, 2013, the Company did not recognize any significant impairment charges.

Derivative Financial

Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency and interest rate

risk. The Company may enter into forward contracts, option contracts, swaps, or other derivative instruments to offset some of the risk on expected future cash flows, on net investments in certain foreign subsidiaries, and on certain existing assets

and liabilities.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the

Company s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may

hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases,

typically for up to 12 months.

To help protect the net investment in a foreign operation from adverse changes in foreign

currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.

To help protect against adverse fluctuations in interest rates, the Company may enter into interest rate swaps, options, or other

instruments to offset a portion of the changes in income or expense due to fluctuations in interest rates.

The Company may

also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the

Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no

assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates.

The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company s accounting treatment for these instruments is based on whether the instruments are

designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in AOCI until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income

( OCI ) as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are

adjusted to fair value through earnings in the financial statement line item to which the derivative relates.

Deferred gains

and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory

purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized as a component of other

income/(expense), net in the same period as the related income or expense is recognized. The Company s hedged foreign currency transactions and hedged interest rate transactions as of March 29, 2014 are expected to occur within 12 months